[The morphological and immunological characteristics of less-differentiated acute myeloid leukemic cells]

Yi-Yan Lai1, Huo Tan, Xu Ye

  • 1Department of Hematology, The Second Affiliated Hospital of Guangzhou Medical College, Guangzhou 510260, China. cq2@21cn.com

Insights

Diagnosing acute myeloid leukemia (AML-Mo) relies on morphology, histochemistry, and immunophenotyping of bone marrow cells. Specific staining patterns and flow cytometry markers aid in accurate AML classification.

Area of Science:

  • Hematology
  • Oncology
  • Cell Biology

Background:

  • Accurate classification of acute myeloid leukemia (AML) is crucial for effective treatment.
  • Less-differentiated subtypes, such as AML with monocytic differentiation (AML-Mo), present diagnostic challenges.
  • Morphological, histochemical, and immunological features are key diagnostic parameters.

Observation:

  • Bone marrow smears from two AML-Mo cases were analyzed using Wright-Giemsa and histochemical stains.
  • Immunophenotyping was performed using flow cytometry to determine cell surface markers.
  • Key observations included negative myeloperoxidase staining, positive periodic acid-Schiff (PAS) staining with fine particles, and positive expression of CD33/CD13, while CD2/CD3/CD10/CD19/CD22 were negative.

Findings:

  • The study identified specific morphological, histochemical, and immunophenotypic profiles for AML-Mo.
  • Negative myeloperoxidase and positive PAS staining, along with CD33/CD13 expression, are characteristic.
  • The combined analysis of these markers provides a robust diagnostic basis for AML-Mo.

Implications:

  • Morphology, histochemistry, and immunophenotyping of bone marrow are essential for diagnosing AML-Mo.
  • Utilizing a panel of monoclonal antibodies in flow cytometry enhances diagnostic accuracy for AML subtypes.
  • This approach aids in precise patient stratification and personalized therapeutic strategies for AML.

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...